nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—DRD1—Parkinson's disease	0.873	1	CbGaD
Propericiazine—DRD1—telencephalic ventricle—Parkinson's disease	0.00765	0.223	CbGeAlD
Propericiazine—DRD1—nerve—Parkinson's disease	0.00482	0.141	CbGeAlD
Propericiazine—ADRA2A—peripheral nervous system—Parkinson's disease	0.00284	0.0826	CbGeAlD
Propericiazine—DRD1—brainstem—Parkinson's disease	0.00207	0.0603	CbGeAlD
Propericiazine—DRD1—forebrain—Parkinson's disease	0.002	0.0582	CbGeAlD
Propericiazine—DRD1—midbrain—Parkinson's disease	0.00132	0.0384	CbGeAlD
Propericiazine—ADRA1B—head—Parkinson's disease	0.00123	0.0358	CbGeAlD
Propericiazine—ADRA1B—nervous system—Parkinson's disease	0.00116	0.0339	CbGeAlD
Propericiazine—DRD1—head—Parkinson's disease	0.00114	0.0333	CbGeAlD
Propericiazine—ADRA1B—central nervous system—Parkinson's disease	0.00112	0.0326	CbGeAlD
Propericiazine—DRD1—nervous system—Parkinson's disease	0.00108	0.0316	CbGeAlD
Propericiazine—DRD1—central nervous system—Parkinson's disease	0.00104	0.0304	CbGeAlD
Propericiazine—ADRA2A—forebrain—Parkinson's disease	0.000916	0.0267	CbGeAlD
Propericiazine—ADRA1B—brain—Parkinson's disease	0.000889	0.0259	CbGeAlD
Propericiazine—DRD1—brain—Parkinson's disease	0.000829	0.0242	CbGeAlD
Propericiazine—ADRA2A—medulla oblongata—Parkinson's disease	0.000662	0.0193	CbGeAlD
Propericiazine—ADRA2A—midbrain—Parkinson's disease	0.000605	0.0176	CbGeAlD
Propericiazine—ADRA2A—spinal cord—Parkinson's disease	0.00059	0.0172	CbGeAlD
Propericiazine—ADRA2A—head—Parkinson's disease	0.000524	0.0153	CbGeAlD
Propericiazine—ADRA2A—nervous system—Parkinson's disease	0.000497	0.0145	CbGeAlD
Propericiazine—ADRA2A—central nervous system—Parkinson's disease	0.000479	0.0139	CbGeAlD
Propericiazine—ADRA2A—cerebellum—Parkinson's disease	0.000468	0.0136	CbGeAlD
Propericiazine—ADRA2A—brain—Parkinson's disease	0.00038	0.0111	CbGeAlD
Propericiazine—Acetophenazine—DRD1—Parkinson's disease	0.000331	0.0285	CrCbGaD
Propericiazine—Domperidone—DRD3—Parkinson's disease	0.000256	0.022	CrCbGaD
Propericiazine—Acetophenazine—DRD2—Parkinson's disease	0.000234	0.0201	CrCbGaD
Propericiazine—Zuclopenthixol—DRD1—Parkinson's disease	0.00021	0.018	CrCbGaD
Propericiazine—Triflupromazine—DRD1—Parkinson's disease	0.000203	0.0175	CrCbGaD
Propericiazine—Clomipramine—GSTP1—Parkinson's disease	0.000189	0.0162	CrCbGaD
Propericiazine—Acepromazine—DRD1—Parkinson's disease	0.000188	0.0162	CrCbGaD
Propericiazine—Thioproperazine—DRD1—Parkinson's disease	0.000184	0.0158	CrCbGaD
Propericiazine—Mesoridazine—DRD3—Parkinson's disease	0.000182	0.0156	CrCbGaD
Propericiazine—Thiothixene—DRD1—Parkinson's disease	0.000181	0.0155	CrCbGaD
Propericiazine—Pipotiazine—DRD1—Parkinson's disease	0.000181	0.0155	CrCbGaD
Propericiazine—Domperidone—DRD2—Parkinson's disease	0.000177	0.0152	CrCbGaD
Propericiazine—Prochlorperazine—DRD3—Parkinson's disease	0.000176	0.0151	CrCbGaD
Propericiazine—Cyamemazine—HTR2A—Parkinson's disease	0.000159	0.0137	CrCbGaD
Propericiazine—Fluphenazine—DRD3—Parkinson's disease	0.000159	0.0137	CrCbGaD
Propericiazine—Fluphenazine—DRD1—Parkinson's disease	0.000156	0.0134	CrCbGaD
Propericiazine—Acepromazine—HTR1A—Parkinson's disease	0.000156	0.0134	CrCbGaD
Propericiazine—Thioproperazine—HTR1A—Parkinson's disease	0.000153	0.0131	CrCbGaD
Propericiazine—Propiomazine—DRD1—Parkinson's disease	0.00015	0.0129	CrCbGaD
Propericiazine—Thiothixene—HTR1A—Parkinson's disease	0.00015	0.0129	CrCbGaD
Propericiazine—Pipotiazine—HTR1A—Parkinson's disease	0.00015	0.0129	CrCbGaD
Propericiazine—Mesoridazine—HTR1A—Parkinson's disease	0.000148	0.0127	CrCbGaD
Propericiazine—Zuclopenthixol—DRD2—Parkinson's disease	0.000148	0.0127	CrCbGaD
Propericiazine—Thioridazine—HTR7—Parkinson's disease	0.000146	0.0125	CrCbGaD
Propericiazine—Triflupromazine—DRD2—Parkinson's disease	0.000143	0.0123	CrCbGaD
Propericiazine—Thioridazine—DRD1—Parkinson's disease	0.000135	0.0116	CrCbGaD
Propericiazine—Perphenazine—HTR7—Parkinson's disease	0.000134	0.0115	CrCbGaD
Propericiazine—Acepromazine—DRD2—Parkinson's disease	0.000133	0.0114	CrCbGaD
Propericiazine—Quetiapine—HTR7—Parkinson's disease	0.000131	0.0113	CrCbGaD
Propericiazine—Methotrimeprazine—DRD3—Parkinson's disease	0.000131	0.0112	CrCbGaD
Propericiazine—Fluphenazine—HTR1A—Parkinson's disease	0.00013	0.0111	CrCbGaD
Propericiazine—Thioproperazine—DRD2—Parkinson's disease	0.00013	0.0111	CrCbGaD
Propericiazine—Methotrimeprazine—DRD1—Parkinson's disease	0.000128	0.011	CrCbGaD
Propericiazine—Thiothixene—DRD2—Parkinson's disease	0.000127	0.0109	CrCbGaD
Propericiazine—Pipotiazine—DRD2—Parkinson's disease	0.000127	0.0109	CrCbGaD
Propericiazine—Mequitazine—CYP2D6—Parkinson's disease	0.000127	0.0109	CrCbGaD
Propericiazine—Mesoridazine—DRD2—Parkinson's disease	0.000126	0.0108	CrCbGaD
Propericiazine—Domperidone—CYP2D6—Parkinson's disease	0.000125	0.0107	CrCbGaD
Propericiazine—Perphenazine—DRD1—Parkinson's disease	0.000124	0.0106	CrCbGaD
Propericiazine—Quetiapine—DRD3—Parkinson's disease	0.000123	0.0106	CrCbGaD
Propericiazine—Prochlorperazine—DRD2—Parkinson's disease	0.000122	0.0105	CrCbGaD
Propericiazine—Quetiapine—DRD1—Parkinson's disease	0.000121	0.0104	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000117	0.00144	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000116	0.00143	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR1A—Parkinson's disease	0.000115	0.00142	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PENK—Parkinson's disease	0.000115	0.00142	CbGpPWpGaD
Propericiazine—Zuclopenthixol—HTR2A—Parkinson's disease	0.000114	0.00981	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—TAC1—Parkinson's disease	0.000114	0.0014	CbGpPWpGaD
Propericiazine—Thioridazine—HTR1A—Parkinson's disease	0.000112	0.0096	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—DRD1—Parkinson's disease	0.000111	0.00138	CbGpPWpGaD
Propericiazine—Promazine—DRD1—Parkinson's disease	0.000111	0.00957	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—GRK5—Parkinson's disease	0.000111	0.00137	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.000111	0.00136	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000111	0.00136	CbGpPWpGaD
Propericiazine—Fluphenazine—DRD2—Parkinson's disease	0.00011	0.00946	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00011	0.00135	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GRM4—Parkinson's disease	0.00011	0.00135	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00011	0.00135	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—DRD3—Parkinson's disease	0.000108	0.00133	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000108	0.00133	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR7—Parkinson's disease	0.000106	0.00912	CrCbGaD
Propericiazine—Fluphenazine—CYP2E1—Parkinson's disease	0.000106	0.00911	CrCbGaD
Propericiazine—Propiomazine—DRD2—Parkinson's disease	0.000106	0.0091	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000106	0.00131	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000106	0.00131	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DGKQ—Parkinson's disease	0.000106	0.0013	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GPR37—Parkinson's disease	0.000106	0.0013	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PDYN—Parkinson's disease	0.000105	0.0013	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000105	0.00129	CbGpPWpGaD
Propericiazine—Zuclopenthixol—CYP2D6—Parkinson's disease	0.000104	0.00898	CrCbGaD
Propericiazine—ADRA1B—Signaling Pathways—VPS35—Parkinson's disease	0.000104	0.00129	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PENK—Parkinson's disease	0.000104	0.00128	CbGpPWpGaD
Propericiazine—Trifluoperazine—HTR1A—Parkinson's disease	0.000104	0.00891	CrCbGaD
Propericiazine—Perphenazine—HTR1A—Parkinson's disease	0.000103	0.00881	CrCbGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000103	0.00127	CbGpPWpGaD
Propericiazine—Acepromazine—HTR2A—Parkinson's disease	0.000102	0.0088	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GRK5—Parkinson's disease	0.000101	0.00125	CbGpPWpGaD
Propericiazine—Quetiapine—HTR1A—Parkinson's disease	0.000101	0.00864	CrCbGaD
Propericiazine—Thioproperazine—HTR2A—Parkinson's disease	0.0001	0.0086	CrCbGaD
Propericiazine—Chlorpromazine—DRD3—Parkinson's disease	9.98e-05	0.00858	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—GRM4—Parkinson's disease	9.95e-05	0.00123	CbGpPWpGaD
Propericiazine—Thiothixene—HTR2A—Parkinson's disease	9.85e-05	0.00846	CrCbGaD
Propericiazine—Pipotiazine—HTR2A—Parkinson's disease	9.85e-05	0.00846	CrCbGaD
Propericiazine—Chlorpromazine—DRD1—Parkinson's disease	9.8e-05	0.00842	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—GRM5—Parkinson's disease	9.79e-05	0.00121	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR7—Parkinson's disease	9.75e-05	0.0012	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—DRD2—Parkinson's disease	9.75e-05	0.0012	CbGpPWpGaD
Propericiazine—Mesoridazine—HTR2A—Parkinson's disease	9.72e-05	0.00835	CrCbGaD
Propericiazine—DRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	9.66e-05	0.00119	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MCCC1—Parkinson's disease	9.58e-05	0.00118	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ND3—Parkinson's disease	9.58e-05	0.00118	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—EDN1—Parkinson's disease	9.54e-05	0.00118	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR1A—Parkinson's disease	9.52e-05	0.00118	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PDYN—Parkinson's disease	9.5e-05	0.00117	CbGpPWpGaD
Propericiazine—Thioridazine—DRD2—Parkinson's disease	9.49e-05	0.00815	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—PENK—Parkinson's disease	9.43e-05	0.00116	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—TAC1—Parkinson's disease	9.37e-05	0.00116	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—DRD1—Parkinson's disease	9.19e-05	0.00114	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.17e-05	0.00113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GRK5—Parkinson's disease	9.16e-05	0.00113	CbGpPWpGaD
Propericiazine—Thioridazine—CYP2E1—Parkinson's disease	9.13e-05	0.00785	CrCbGaD
Propericiazine—Methotrimeprazine—DRD2—Parkinson's disease	9.06e-05	0.00778	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GRM4—Parkinson's disease	9.04e-05	0.00112	CbGpPWpGaD
Propericiazine—Thiothixene—CYP2D6—Parkinson's disease	9e-05	0.00774	CrCbGaD
Propericiazine—Pipotiazine—CYP2D6—Parkinson's disease	9e-05	0.00774	CrCbGaD
Propericiazine—ADRA2A—Metabolism—TALDO1—Parkinson's disease	9e-05	0.00111	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—OMD—Parkinson's disease	9e-05	0.00111	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.97e-05	0.00111	CbGpPWpGaD
Propericiazine—Domperidone—ABCB1—Parkinson's disease	8.93e-05	0.00767	CrCbGaD
Propericiazine—Promethazine—DRD2—Parkinson's disease	8.92e-05	0.00767	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—DRD3—Parkinson's disease	8.9e-05	0.0011	CbGpPWpGaD
Propericiazine—Mesoridazine—CYP2D6—Parkinson's disease	8.89e-05	0.00764	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—GRM5—Parkinson's disease	8.83e-05	0.00109	CbGpPWpGaD
Propericiazine—Trifluoperazine—DRD2—Parkinson's disease	8.8e-05	0.00756	CrCbGaD
Propericiazine—Methotrimeprazine—CYP2E1—Parkinson's disease	8.72e-05	0.00749	CrCbGaD
Propericiazine—Perphenazine—DRD2—Parkinson's disease	8.71e-05	0.00748	CrCbGaD
Propericiazine—ADRA1B—Signaling Pathways—DGKQ—Parkinson's disease	8.65e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GPR37—Parkinson's disease	8.65e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	8.64e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PDYN—Parkinson's disease	8.63e-05	0.00107	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VPS35—Parkinson's disease	8.61e-05	0.00106	CbGpPWpGaD
Propericiazine—Prochlorperazine—CYP2D6—Parkinson's disease	8.61e-05	0.00739	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PENK—Parkinson's disease	8.57e-05	0.00106	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—FGB—Parkinson's disease	8.55e-05	0.00106	CbGpPWpGaD
Propericiazine—Quetiapine—DRD2—Parkinson's disease	8.54e-05	0.00734	CrCbGaD
Propericiazine—ADRA2A—Metabolism—NDUFB11—Parkinson's disease	8.54e-05	0.00105	CbGpPWpGaD
Propericiazine—Fluphenazine—HTR2A—Parkinson's disease	8.51e-05	0.00731	CrCbGaD
Propericiazine—DRD1—Circadian rythm related genes—MAPK8—Parkinson's disease	8.49e-05	0.00105	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	8.46e-05	0.00105	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RIT2—Parkinson's disease	8.44e-05	0.00104	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR2A—Parkinson's disease	8.34e-05	0.00103	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	8.33e-05	0.00103	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—GRM4—Parkinson's disease	8.21e-05	0.00101	CbGpPWpGaD
Propericiazine—Propiomazine—HTR2A—Parkinson's disease	8.19e-05	0.00703	CrCbGaD
Propericiazine—ADRA2A—Metabolism—GCH1—Parkinson's disease	8.14e-05	0.00101	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR1A—Parkinson's disease	8.14e-05	0.00699	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR7—Parkinson's disease	8.05e-05	0.000994	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—DRD2—Parkinson's disease	8.05e-05	0.000994	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—GRM5—Parkinson's disease	8.02e-05	0.000991	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GRK5—Parkinson's disease	8e-05	0.000988	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	7.96e-05	0.000983	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PPP1R1B—Parkinson's disease	7.91e-05	0.000977	CbGpPWpGaD
Propericiazine—Promazine—DRD2—Parkinson's disease	7.85e-05	0.00675	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PDYN—Parkinson's disease	7.84e-05	0.000968	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—TAC1—Parkinson's disease	7.84e-05	0.000968	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—EDN1—Parkinson's disease	7.81e-05	0.000964	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PENK—Parkinson's disease	7.79e-05	0.000961	CbGpPWpGaD
Propericiazine—Clomipramine—HTR2A—Parkinson's disease	7.78e-05	0.00669	CrCbGaD
Propericiazine—Fluphenazine—CYP2D6—Parkinson's disease	7.78e-05	0.00669	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.51e-05	0.000927	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—DRD3—Parkinson's disease	7.44e-05	0.000919	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.4e-05	0.000914	CbGpPWpGaD
Propericiazine—Thioridazine—HTR2A—Parkinson's disease	7.33e-05	0.0063	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—GRM5—Parkinson's disease	7.29e-05	0.0009	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—DBH—Parkinson's disease	7.26e-05	0.000896	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—FBP1—Parkinson's disease	7.26e-05	0.000896	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GBA—Parkinson's disease	7.26e-05	0.000896	CbGpPWpGaD
Propericiazine—Triflupromazine—ABCB1—Parkinson's disease	7.23e-05	0.00621	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—HTR1A—Parkinson's disease	7.23e-05	0.000892	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GRM4—Parkinson's disease	7.18e-05	0.000886	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GPR37—Parkinson's disease	7.14e-05	0.000881	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DGKQ—Parkinson's disease	7.14e-05	0.000881	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PDYN—Parkinson's disease	7.12e-05	0.000879	CbGpPWpGaD
Propericiazine—Clomipramine—CYP2D6—Parkinson's disease	7.12e-05	0.00612	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—TAC1—Parkinson's disease	7.12e-05	0.000879	CbGpPWpGaD
Propericiazine—Methotrimeprazine—HTR2A—Parkinson's disease	7e-05	0.00601	CrCbGaD
Propericiazine—DRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.95e-05	0.000858	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RIT2—Parkinson's disease	6.91e-05	0.000854	CbGpPWpGaD
Propericiazine—Chlorpromazine—DRD2—Parkinson's disease	6.91e-05	0.00594	CrCbGaD
Propericiazine—Promethazine—HTR2A—Parkinson's disease	6.9e-05	0.00592	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR2A—Parkinson's disease	6.83e-05	0.000844	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADORA2A—Parkinson's disease	6.82e-05	0.000842	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PENK—Parkinson's disease	6.8e-05	0.00084	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAG—Parkinson's disease	6.8e-05	0.00084	CbGpPWpGaD
Propericiazine—Trifluoperazine—HTR2A—Parkinson's disease	6.8e-05	0.00585	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—DRD3—Parkinson's disease	6.76e-05	0.000835	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—DRD2—Parkinson's disease	6.73e-05	0.000831	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR7—Parkinson's disease	6.73e-05	0.000831	CbGpPWpGaD
Propericiazine—Perphenazine—HTR2A—Parkinson's disease	6.73e-05	0.00578	CrCbGaD
Propericiazine—Thioridazine—CYP2D6—Parkinson's disease	6.71e-05	0.00576	CrCbGaD
Propericiazine—Chlorpromazine—CYP2E1—Parkinson's disease	6.65e-05	0.00571	CrCbGaD
Propericiazine—ADRA2A—Signaling by GPCR—GRM5—Parkinson's disease	6.62e-05	0.000817	CbGpPWpGaD
Propericiazine—Quetiapine—HTR2A—Parkinson's disease	6.6e-05	0.00567	CrCbGaD
Propericiazine—ADRA1B—Signaling Pathways—GRK5—Parkinson's disease	6.55e-05	0.000809	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PPP1R1B—Parkinson's disease	6.53e-05	0.000806	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR1A—Parkinson's disease	6.52e-05	0.000805	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—EDN1—Parkinson's disease	6.45e-05	0.000796	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—TAC1—Parkinson's disease	6.42e-05	0.000793	CbGpPWpGaD
Propericiazine—Methotrimeprazine—CYP2D6—Parkinson's disease	6.4e-05	0.0055	CrCbGaD
Propericiazine—ADRA2A—Hemostasis—SOD1—Parkinson's disease	6.35e-05	0.000784	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	6.31e-05	0.000779	CbGpPWpGaD
Propericiazine—Promethazine—CYP2D6—Parkinson's disease	6.31e-05	0.00542	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—DRD1—Parkinson's disease	6.29e-05	0.000777	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PDYN—Parkinson's disease	6.22e-05	0.000769	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.2e-05	0.000765	CbGpPWpGaD
Propericiazine—Perphenazine—CYP2D6—Parkinson's disease	6.15e-05	0.00529	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—DRD2—Parkinson's disease	6.11e-05	0.000755	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR7—Parkinson's disease	6.11e-05	0.000755	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—DRD3—Parkinson's disease	6.1e-05	0.000753	CbGpPWpGaD
Propericiazine—Promazine—HTR2A—Parkinson's disease	6.07e-05	0.00521	CrCbGaD
Propericiazine—ADRA2A—Hemostasis—ABL1—Parkinson's disease	6.06e-05	0.000748	CbGpPWpGaD
Propericiazine—Quetiapine—CYP2D6—Parkinson's disease	6.03e-05	0.00518	CrCbGaD
Propericiazine—ADRA2A—Hemostasis—IGF2—Parkinson's disease	6.03e-05	0.000745	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR1A—Parkinson's disease	5.92e-05	0.000731	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GRM4—Parkinson's disease	5.88e-05	0.000726	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GFAP—Parkinson's disease	5.85e-05	0.000723	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—TAC1—Parkinson's disease	5.83e-05	0.00072	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GRM5—Parkinson's disease	5.79e-05	0.000715	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—DRD1—Parkinson's disease	5.72e-05	0.000706	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RIT2—Parkinson's disease	5.71e-05	0.000705	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HGF—Parkinson's disease	5.7e-05	0.000704	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.69e-05	0.000703	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR2A—Parkinson's disease	5.64e-05	0.000696	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADORA2A—Parkinson's disease	5.63e-05	0.000695	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PENK—Parkinson's disease	5.57e-05	0.000688	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAG—Parkinson's disease	5.57e-05	0.000688	CbGpPWpGaD
Propericiazine—Fluphenazine—ABCB1—Parkinson's disease	5.56e-05	0.00477	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—DRD3—Parkinson's disease	5.54e-05	0.000684	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR7—Parkinson's disease	5.51e-05	0.000681	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—DRD2—Parkinson's disease	5.51e-05	0.000681	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—IL6—Parkinson's disease	5.42e-05	0.000669	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GRK5—Parkinson's disease	5.41e-05	0.000668	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—EDN1—Parkinson's disease	5.39e-05	0.000665	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	5.38e-05	0.000664	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR2A—Parkinson's disease	5.34e-05	0.00459	CrCbGaD
Propericiazine—ADRA2A—Metabolism—DDC—Parkinson's disease	5.33e-05	0.000658	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—TAC1—Parkinson's disease	5.3e-05	0.000654	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—DRD1—Parkinson's disease	5.19e-05	0.000641	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRBK1—Parkinson's disease	5.17e-05	0.000638	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDYN—Parkinson's disease	5.1e-05	0.000629	CbGpPWpGaD
Propericiazine—Clomipramine—ABCB1—Parkinson's disease	5.08e-05	0.00437	CrCbGaD
Propericiazine—DRD1—Signaling Pathways—FGF20—Parkinson's disease	5.07e-05	0.000627	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—DRD3—Parkinson's disease	5.03e-05	0.000621	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTA4—Parkinson's disease	5.03e-05	0.000621	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—DRD2—Parkinson's disease	5.01e-05	0.000618	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR7—Parkinson's disease	5.01e-05	0.000618	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADORA2A—Parkinson's disease	4.92e-05	0.000608	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EDN1—Parkinson's disease	4.89e-05	0.000604	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR1A—Parkinson's disease	4.88e-05	0.000603	CbGpPWpGaD
Propericiazine—Chlorpromazine—CYP2D6—Parkinson's disease	4.88e-05	0.00419	CrCbGaD
Propericiazine—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	4.85e-05	0.000599	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	4.81e-05	0.000594	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	4.79e-05	0.000592	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	4.74e-05	0.000585	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	4.72e-05	0.000582	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.71e-05	0.000582	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.7e-05	0.00058	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	4.6e-05	0.000568	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	4.6e-05	0.000568	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	4.57e-05	0.000564	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	4.55e-05	0.000562	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	4.55e-05	0.000562	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INSR—Parkinson's disease	4.54e-05	0.000561	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	4.53e-05	0.000559	CbGpPWpGaD
Propericiazine—Promethazine—ABCB1—Parkinson's disease	4.5e-05	0.00387	CrCbGaD
Propericiazine—ADRA2A—Metabolism—MAOB—Parkinson's disease	4.48e-05	0.000554	CbGpPWpGaD
Propericiazine—Trifluoperazine—ABCB1—Parkinson's disease	4.44e-05	0.00382	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	4.41e-05	0.000545	CbGpPWpGaD
Propericiazine—Quetiapine—ABCB1—Parkinson's disease	4.31e-05	0.0037	CrCbGaD
Propericiazine—DRD1—Signaling Pathways—FGB—Parkinson's disease	4.29e-05	0.00053	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2A—Parkinson's disease	4.28e-05	0.000529	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR1A—Parkinson's disease	4.27e-05	0.000527	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	4.27e-05	0.000527	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	4.21e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.2e-05	0.000519	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TAC1—Parkinson's disease	4.2e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	4.15e-05	0.000513	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	4.13e-05	0.00051	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	4.13e-05	0.00051	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	4.03e-05	0.000498	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	4.01e-05	0.000495	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DRD3—Parkinson's disease	3.99e-05	0.000493	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	3.95e-05	0.000488	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	3.91e-05	0.000483	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	3.86e-05	0.000477	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRBK1—Parkinson's disease	3.73e-05	0.00046	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	3.72e-05	0.000459	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	3.64e-05	0.00045	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR7—Parkinson's disease	3.61e-05	0.000446	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—DRD2—Parkinson's disease	3.61e-05	0.000446	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	3.51e-05	0.000434	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	3.51e-05	0.000433	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	3.5e-05	0.000432	CbGpPWpGaD
Propericiazine—Chlorpromazine—ABCB1—Parkinson's disease	3.49e-05	0.003	CrCbGaD
Propericiazine—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	3.44e-05	0.000425	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	3.43e-05	0.000423	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	3.38e-05	0.000417	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	3.33e-05	0.000412	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	3.33e-05	0.000411	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	3.31e-05	0.000408	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CTGF—Parkinson's disease	3.27e-05	0.000404	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	3.27e-05	0.000404	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	3.19e-05	0.000393	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	3.07e-05	0.000379	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	3.05e-05	0.000377	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	3.05e-05	0.000376	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	3.03e-05	0.000374	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NQO1—Parkinson's disease	3.01e-05	0.000372	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—TH—Parkinson's disease	2.97e-05	0.000367	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	2.96e-05	0.000365	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	2.96e-05	0.000365	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	2.93e-05	0.000361	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	2.9e-05	0.000358	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	2.89e-05	0.000357	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	2.89e-05	0.000357	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	2.89e-05	0.000356	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYCS—Parkinson's disease	2.85e-05	0.000352	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	2.84e-05	0.000351	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	2.79e-05	0.000344	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	2.7e-05	0.000333	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NGF—Parkinson's disease	2.66e-05	0.000328	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	2.53e-05	0.000312	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—COMT—Parkinson's disease	2.53e-05	0.000312	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	2.52e-05	0.000311	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	2.51e-05	0.00031	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MAOA—Parkinson's disease	2.51e-05	0.00031	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	2.48e-05	0.000306	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	2.48e-05	0.000306	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	2.44e-05	0.000301	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	2.44e-05	0.000301	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	2.4e-05	0.000296	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	2.38e-05	0.000294	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	2.37e-05	0.000292	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOE—Parkinson's disease	2.35e-05	0.00029	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	2.31e-05	0.000285	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—Parkinson's disease	2.21e-05	0.000273	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	2.18e-05	0.000269	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	2.07e-05	0.000256	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	2.05e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	2.04e-05	0.000252	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—INS—Parkinson's disease	2.01e-05	0.000248	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	1.98e-05	0.000244	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	1.95e-05	0.000241	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	1.93e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOE—Parkinson's disease	1.9e-05	0.000235	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	1.8e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	1.71e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	1.64e-05	0.000203	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—INS—Parkinson's disease	1.62e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	1.59e-05	0.000196	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	1.5e-05	0.000185	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	1.49e-05	0.000183	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	1.37e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	1.36e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	1.22e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	1.22e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.13e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.01e-05	0.000125	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	9.29e-06	0.000115	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—Parkinson's disease	8.78e-06	0.000108	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	7.19e-06	8.88e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	5.93e-06	7.33e-05	CbGpPWpGaD
